Skip to main content
. 2001 Mar;3(2):125–131. doi: 10.1038/sj.neo.7900138

Figure 5.

Figure 5

The effect of IB-MECA on the development of lung metastases in mice inoculated with B16-F10 melanoma cells. IB-MECA was administered orally daily at a dosage of 3 or 6 µg/kg body weight. A dose-dependent inhibition of lung metastatic foci is depicted.